Experts have warned Bangladesh that deadly outbreaks of diphtheria, whooping cough and polio could follow an ongoing measles ...

The Hepatitis B Foundation notes that there’s still no complete cure for hepatitis B. It advises regular checkups with a ...

Today we shine a light on a study that suggests just how misguided and potentially dangerous new US hepatitis B vaccination ...

The findings run counter to updated guidance issued in January 2025 by the U.S. Centers for Disease Control and Prevention ...

GSK received FDA approval for Hibsago, an antisense oligonucleotide injection used with existing antiviral therapy to treat ...

A contentious, United States-funded clinical trial involving newborns in Guinea-Bissau has been halted following mounting concerns over bioethics, coercive consent and the dangers of deliberately ...

The Food and Drug Administration approved Hibsago (bepirovirsen) on Oct. 20, 2026, calling it the first-of-its-kind treatment ...

Two viruses can attack the same organ, yet the way they spread and the damage they cause are remarkably different. While ...

For the first time, many people living with chronic hepatitis B may have a functional cure at hand. The US Food and Drug ...

People with cancer: ASCO recommends universal hepatitis B screening for patients with cancer who expect to receive systemic anticancer therapy, meaning treatment that travels through the body, such as ...

GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to make copies of itself and viral proteins. This drug was licensed from ...

A new study projects that delaying or omitting the hepatitis B shot at birth could increase chronic infections among children by 83%. Under the direction of Health Secretary RFK Jr., the CDC ended its ...